NewsWatch: Why the new SEC sheriff could be trouble for companies like Te...

Merck Asks FDA to Authorize Promising Covid-19 Pill The filing comes shortly after data from a late-stage study showed that the antiviral drug, molnupiravir, cut the risk of hospitalization or death by about 50% in high-risk people with mild to moderate Covid-19.  Oct. 11, 2021 at 6:00 a.m. ET by Jared S. Hopkins

NewsWatch: Why the new SEC sheriff could be trouble for companies like Te...

Merck Asks FDA to Authorize Promising Covid-19 Pill

The filing comes shortly after data from a late-stage study showed that the antiviral drug, molnupiravir, cut the risk of hospitalization or death by about 50% in high-risk people with mild to moderate Covid-19.